Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

486
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
486
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

584
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
584
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.6K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

152
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
152
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

674
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
674
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

567
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
567

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary Clinical Practices in Korean Patients With Coronary Chronic Total Occlusion: Results From the K-CTO Nationwide Retrospective Registry.

Korean circulation journal·2026
Same author

Clinical Outcomes of Complete Revascularization in Acute Myocardial Infarction Patients With High Bleeding Risk and Multivessel Disease.

Journal of the American Heart Association·2026
Same author

Video frame interpolation for coronary angiography using latent flow matching.

NPJ digital medicine·2026
Same author

Comparative effectiveness of Orsiro, Xience, Synergy, and Resolute stent in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry study.

Coronary artery disease·2026
Same author

Comparison of Clinical Outcomes Between Incomplete and Complete Revascularization in NSTEMI Patients With Multivessel Disease.

JACC. Asia·2026
Same author

Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.

The New England journal of medicine·2026

Related Experiment Video

Updated: Nov 8, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Pre-existing and machine learning-based models for cardiovascular risk prediction.

Sang-Yeong Cho1, Sun-Hwa Kim2, Si-Hyuck Kang3,4

  • 1Department of Cardiology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Korea.

Scientific Reports
|April 27, 2021
PubMed
Summary

Machine learning models significantly improve cardiovascular disease risk prediction in Korean adults. A neural network model outperformed existing tools, aiding primary prevention and clinical decisions.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.0K

Related Experiment Videos

Last Updated: Nov 8, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.0K

Area of Science:

  • Cardiology
  • Biostatistics
  • Artificial Intelligence in Healthcare

Background:

  • Cardiovascular disease (CVD) risk prediction is crucial for primary prevention strategies.
  • Large, complex healthcare datasets necessitate advanced analytical methods like machine learning.
  • Evaluating existing CVD risk prediction models is essential for identifying areas for improvement.

Purpose of the Study:

  • To assess the discrimination and calibration of established cardiovascular risk prediction models.
  • To develop and evaluate novel machine learning-based algorithms for cardiovascular risk prediction.
  • To compare the performance of machine learning models against traditional models in a Korean population.

Main Methods:

  • Analysis of data from 222,998 Korean adults aged 40-79 without prior CVD or lipid-lowering therapy.
  • Comparative assessment of pre-existing models (e.g., Pooled Cohort Equation, Framingham Risk Score) and machine learning algorithms (logistic regression, treebag, random forest, adaboost, neural network).
  • Evaluation metrics included C-statistics for discrimination and Hosmer-Lemeshow test for calibration.

Main Results:

  • Pre-existing models demonstrated moderate to good discrimination (C-statistics 0.70-0.80).
  • The neural network model achieved a higher C-statistic (0.751) than the Pooled Cohort Equation (0.738).
  • The neural network model showed improved calibration and agreement between predicted and observed risks compared to traditional models.

Conclusions:

  • Machine learning-based algorithms, particularly neural networks, offer superior performance for cardiovascular risk prediction in statin-naïve Korean adults compared to existing models.
  • These advanced models can enhance accuracy in risk assessment for primary prevention.
  • The developed machine learning model is suitable for adoption in clinical decision-making processes.